HAP Trading’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $293K | Sell |
102,000
-49,200
| -33% | -$383K | 0.02% | 340 |
|
|
2025
Q2 | $166K | Buy |
151,200
+101,100
| +202% | +$669K | 0.02% | 355 |
|
|
2025
Q1 | $14.5K | Buy |
+50,100
| New | +$414K | ﹤0.01% | 584 |
|
|
2023
Q1 | – | Sell |
-66,600
| Closed | -$7K | – | 1529 |
|
|
2022
Q4 | $7K | Sell |
66,600
-38,600
| -37% | -$681K | ﹤0.01% | 1187 |
|
|
2022
Q3 | $11K | Buy |
105,200
+93,400
| +792% | +$4.05M | ﹤0.01% | 1309 |
|
|
2022
Q2 | $51K | Sell |
11,800
-3,900
| -25% | -$202K | ﹤0.01% | 1052 |
|
|
2022
Q1 | $44K | Sell |
15,700
-31,700
| -67% | -$2.83M | ﹤0.01% | 1303 |
|
|
2021
Q4 | $2.82M | Buy |
47,400
+4,900
| +12% | +$842K | 0.08% | 233 |
|
|
2021
Q3 | $4.01M | Buy |
42,500
+2,800
| +7% | +$617K | 0.13% | 159 |
|
|
2021
Q2 | $4.54M | Sell |
39,700
-57,100
| -59% | -$10.5M | 0.14% | 135 |
|
|
2021
Q1 | $5.88M | Buy |
96,800
+12,400
| +15% | +$2.47M | 0.31% | 60 |
|
|
2020
Q4 | $1.79M | Buy |
84,400
+52,100
| +161% | +$5.54M | 0.05% | 289 |
|
|
2020
Q3 | $1.36M | Sell |
32,300
-500
| -2% | -$60.9K | 0.07% | 208 |
|
|
2020
Q2 | $1.5M | Sell |
32,800
-8,000
| -20% | -$306K | 0.08% | 216 |
|
|
2020
Q1 | $165K | Buy |
40,800
+6,795
| +20% | +$57.5K | 0.01% | 577 |
|
|
2019
Q4 | $18K | Buy |
34,005
+15,900
| +88% | +$69K | ﹤0.01% | 908 |
|
|
2019
Q3 | $20K | Buy |
+18,105
| New | +$99.1K | ﹤0.01% | 929 |
|
|
2019
Q1 | – | Sell |
-2,260
| Closed | -$13K | – | 1293 |
|
|
2018
Q4 | $13K | Buy |
2,260
+500
| +28% | +$19.4K | ﹤0.01% | 929 |
|
|
2018
Q3 | $14K | Buy |
1,760
+475
| +37% | +$13.4K | ﹤0.01% | 806 |
|
|
2018
Q2 | $4K | Buy |
1,285
+690
| +116% | +$23.3K | ﹤0.01% | 932 |
|
|
2018
Q1 | $3K | Sell |
595
-2,090
| -78% | -$84K | ﹤0.01% | 875 |
|
|
2017
Q4 | $1K | Buy |
+2,685
| New | +$65.5K | ﹤0.01% | 967 |
|
|
2017
Q3 | – | Sell |
-2,170
| Closed | -$1K | – | 1014 |
|
|
2017
Q2 | $1K | Sell |
2,170
-80
| -4% | -$1.57K | ﹤0.01% | 913 |
|
|
2017
Q1 | $2K | Sell |
2,250
-1,275
| -36% | -$35.1K | ﹤0.01% | 1001 |
|
|
2016
Q4 | $3K | Sell |
3,525
-635
| -15% | -$18.5K | ﹤0.01% | 924 |
|
|
2016
Q3 | $7K | Buy |
4,160
+2,645
| +175% | +$341K | ﹤0.01% | 1015 |
|
|
2016
Q2 | $33K | Hold |
1,515
| – | – | ﹤0.01% | 666 |
|
|
2016
Q1 | $12K | Sell |
1,515
-2,000
| -57% | -$215K | ﹤0.01% | 669 |
|
|
2015
Q4 | $57K | Buy |
3,515
+1,515
| +76% | +$233K | ﹤0.01% | 622 |
|
|
2015
Q3 | $10K | Buy |
+2,000
| New | +$448K | ﹤0.01% | 887 |
|
|
2014
Q4 | – | Sell |
-1,575
| Closed | -$10K | – | 1167 |
|
|
2014
Q3 | $10K | Hold |
1,575
| – | – | ﹤0.01% | 905 |
|
|
2014
Q2 | $33K | Buy |
+1,575
| New | +$138K | ﹤0.01% | 772 |
|
Other funds holding NVAX
SCM
S
HAP Trading's NVAX Position: Q2 2022 in Review
HAP Trading sold out of Novavax (NVAX) in Q2 2022, closing a stake of 64,638 shares — an estimated $3.35M sold.
HAP Trading first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $4.76M in Q1 2022. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- HAP Trading reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- HAP Trading sold 64,638 Novavax shares in Q2 2022, an estimated $3.35M.
- HAP Trading first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
- HAP Trading's Novavax position peaked at $4.76M in Q1 2022.
- 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.